Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
This is to announce that Dr. Ashutosh Raghuvanshi, VC, MD and Group CEO of Narayana Hrudayalaya Ltd (NH), has tendered his resignation from the services of the company. - The Pharma Times | Pharma & Health Care News Portal
Archives

This is to announce that Dr. Ashutosh Raghuvanshi, VC, MD and Group CEO of Narayana Hrudayalaya Ltd (NH), has tendered his resignation from the services of the company.

New Delhi, February 06, 2019: Dr. Raghuvanshi has decided to move on from NH on personal grounds, after serving the company for 18 years. Dr. Raghuvanshi’s resignation has been deliberated by the Board of NH and stands accepted.
The Board of NH would like to make the following announcements regarding new appointments –
1. Dr. Emmanuel Rupert has been appointed MD & Group CEO, to take over from Dr. Raghuvanshi. Dr. Rupert has been associated with NH since 2000 and has been part of the founding team at NH. He started his career with NH as Sr. Consultant in Cardiac Anaesthesiology and Intensive Care in the year 2000. Dr. Rupert has served as the Group Director – Medical Services since August 2018. Dr. Rupert’s appointment will be formalised immediately following the relieving of Dr. Raghuvanshi from the services of the company.
2. Mr. Viren Shetty has been appointed Group COO of the company. Mr. Viren Shetty, an MBA from Stanford Business School, has been on the Board of the company in the capacity of an Executive Director, and has been Sr. VP – Strategy since 2012.
Dr. Devi Prasad Shetty, Chairman of the Board, would like to thank Dr. Raghuvanshi for his long-standing association with the NH family and wishes him all the very best for his future endeavours.
On behalf of the Board, Dr. Devi Prasad Shetty, welcomes Dr. Emmanuel Rupert and Mr. Viren Shetty in their new roles and wishes them success in taking the company to greater heights.
Corporate Comm India(CCI Newswire)
The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

1 day ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

3 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

1 week ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

2 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago